Atlas Trials

Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years

Clinical trial NCT00994760 · COMPLETED

Trial details

NCT number
NCT00994760
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Breakthrough PainCancer
Start date
2009-09-01
Primary completion
2010-09-01
Enrollment
131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.